Welichem Biotech Inc. – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 1 PAGES: 32

Welichem Biotech Inc. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Welichem Biotech Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Welichem Biotech Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Welichem Biotech Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Welichem Biotech Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Welichem Biotech Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Welichem Biotech Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Welichem Biotech Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Welichem Biotech Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities b

More Info
									Welichem Biotech Inc. – Product Pipeline Review – Q1
                        2011
                                                                                          Reference Code: GMDHC1214CDB

                                                                                                Publication Date: MAY 2011




Welichem Biotech Inc. – Product Pipeline Review – Q1 2011                                   GMDHC1214CDB / Published MAY 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Welichem Biotech Inc. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        3
List of Figures                                                                                                       4
Welichem Biotech Inc. Snapshot                                                                                        5
    Welichem Biotech Inc. Overview                                                                                    5
    Key Information                                                                                                   5
    Key Facts                                                                                                         5
Welichem Biotech Inc. – Research and Development Overview                                                             6
    Key Therapeutic Areas                                                                                             6
Welichem Biotech Inc. – Pipeline Review                                                                               9
    Pipeline Products by Stage of Development                                                                         9
    Pipeline Products – Monotherapy                                                                                  10
    Pipeline Products – Combination Treatment Modalities                                                             11
Welichem Biotech Inc. – Pipeline Products Glance                                                                     12
    Welichem Biotech Inc. Clinical Stage Pipeline Products                                                           12
         Phase II Products/Combination Treatment Modalities                                                          12
         Phase I Products/Combination Treatment Modalities                                                           13
    Welichem Biotech Inc.–Early Stage Pipeline Products                                                              14
         Pre-Clinical Products/Combination Treatment Modalities                                                      14
Welichem Biotech Inc. – Drug Profiles                                                                                15
    WBI-1001                                                                                                         15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    WBI-2100                                                                                                         16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    WBI-2100 + Cisplatin                                                                                             17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    WBI-2100 + Dacarbazine                                                                                           18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18
    WBI-2100 + Gemcitabine                                                                                           19
         Product Description                                                                                         19
         Mechanism of Action                                                                                         19
         R&D Progress                                                                                                19
    WBI-2100 + Taxol                                                                                                 20
         Product Description                                                                                         20
         Mechanism of Action                                                                                         20
         R&D Progress                                                                                                20
Welichem Biotech Inc. – Pipeline Analysis                                                                            21
    Welichem Biotech Inc. – Pipeline Products by Therapeutic Class                                                   21




Welichem Biotech Inc. – Product Pipeline Review – Q1 2011                                 GMDHC1214CDB / Published MAY 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                             Page(2)
Welichem Biotech Inc. – Product Pipeline Review



    Welichem Biotech Inc. - Pipeline Products By Target                                                              23
    Welichem Biotech Inc. – Pipeline Products by Route of Administration                                             24
    Welichem Biotech Inc. – Pipeline Products by Molecule Type                                                       25
Welichem Biotech Inc. – Recent Pipeline Updates                                                                      26
Welichem Biotech Inc. – Locations And Subsidiaries                                                                   27
    Head Office                                                                                                      27
Financial Deals Landscape                                                                                            28
    Welichem Biotech Inc., Deals Summary, 2004 to 2011                                                               28
    Welichem Biotech Inc. Detailed Deal Summary                                                                      29
         Equity Offering                                                                                             29
         Welichem Biotech Completes Non-Brokered Private Placement Of $3.46 Million                                  29
Appendix                                                                                                             31
    Methodology                                                                                                      31
         Coverage                                                                                                    31
         Secondary Research                                                                                          31
         Primary Research                                                                                            31
         Expert Panel Validation                                                                                     32
    Contact Us                                                                                                       32
    Disclaimer                                                                                                       32




Lis t o f Ta b le s
Welichem Biotech Inc. – Pipeline by Therapy Area and Indication, 2011                                                 7

Welichem Biotech Inc. – Pipeline by Stage of Development, 2011                                                        9

Welichem Biotech Inc. – Monotherapy Products in Pipeline, 2011                                                       10

Welichem 
								
To top